{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T01:46:50Z","timestamp":1775094410015,"version":"3.50.1"},"reference-count":0,"publisher":"Therapeutic Guidelines Limited","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aust Prescr"],"DOI":"10.18773\/austprescr.2026.015","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:52:07Z","timestamp":1775091127000},"page":"74-75","source":"Crossref","is-referenced-by-count":0,"title":["New Drug: Foslevodopa+foscarbidopa for advanced Parkinson disease"],"prefix":"10.18773","volume":"49","member":"39051","published-online":{"date-parts":[[2026,4,7]]},"container-title":["Australian Prescriber"],"original-title":[],"link":[{"URL":"https:\/\/australianprescriber.tg.org.au\/articles\/foslevodopa-foscarbidopa-for-advanced-Parkinson-disease.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:52:15Z","timestamp":1775091135000},"score":1,"resource":{"primary":{"URL":"https:\/\/australianprescriber.tg.org.au\/articles\/foslevodopa-foscarbidopa-for-advanced-Parkinson-disease.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":0,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,4,7]]}},"URL":"https:\/\/doi.org\/10.18773\/austprescr.2026.015","relation":{},"ISSN":["1839-3942"],"issn-type":[{"value":"1839-3942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]}}}